Trulieve Cannabis (TSE:TRUL)
CNQX:TRUL
Canadian Market

Trulieve Cannabis Stock Analysis & Ratings

Trulieve Cannabis Stock Analysis Overview

Smart Score
6
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
The Trulieve Cannabis stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.

Stock Chart

TSE:TRUL

TSE:TRUL Stock Stats

Previous CloseC$29.86
OpenC$30
Bid0 x 0
Ask0 x 0
Today’s RangeC$28.11 - C$30.1
52-Week RangeC$28.11 - C$67.45
Volume334.68K
Average Volume227.72K
Market CapC$3.65B
Beta1.19
P/E Ratio30.1
EPS0.93
Earnings DateApr 13, 2022

Company Description

Trulieve Cannabis

Trulieve Cannabis Corp. engages in the provision of medical cannabis products. The firm cultivates and produces its products in-house and distributes to its branded stores, as well as directly to patients via home delivery. Its products include smokable flower, inhalation, oral, sublingual, topical, inter-nasal, and concentrates. The company was founded on September 21, 2018 and is headquartered in Quincy, FL.
Sector
Basic Materials
Industry
Drug Manufacturers
CEO
N/A
Employees
4,845
Website
www.trulieve.com
ISIN
CA89788C1041
Address
6749 Ben Bostic Road, Quincy, FL, 32351, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

Trulieve Cannabis News


TSE:TRUL FAQ

What was Trulieve Cannabis’s price range in the past 12 months?
Trulieve Cannabis lowest stock price was C$28.11 and its highest was C$67.45 in the past 12 months.
    What is Trulieve Cannabis’s market cap?
    Trulieve Cannabis’s market cap is C$3.65B.
      What is Trulieve Cannabis’s price target?
      The average price target for Trulieve Cannabis is C$84.73. This is based on 7 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
      The highest analyst price target is C$135.00 ,the lowest forecast is C$61.00. The average price target represents 201.10% Increase from the current price of C$28.14.
        What do analysts say about Trulieve Cannabis?
        Trulieve Cannabis’s analyst rating consensus is a ‘Strong Buy. This is based on the ratings of 7 Wall Streets Analysts.
          When is Trulieve Cannabis’s upcoming earnings report date?
          Trulieve Cannabis’s upcoming earnings report date is Apr 13, 2022 which is in 82 days.
            How were Trulieve Cannabis’s earnings last quarter?
            Trulieve Cannabis released its earnings results on Nov 15, 2021. The company reported C$0.175 earnings per share for the quarter, missing the consensus estimate of C$0.331 by -C$0.155.
              Is Trulieve Cannabis overvalued?
              According to Wall Street analysts Trulieve Cannabis’s price is currently Undervalued.
                Does Trulieve Cannabis pay dividends?
                Trulieve Cannabis does not currently pay dividends.
                What is Trulieve Cannabis’s EPS estimate?
                Trulieve Cannabis’s EPS estimate for its next earnings report is not yet available.
                How many shares outstanding does Trulieve Cannabis have?
                Trulieve Cannabis has 129,530,000 shares outstanding.
                  What happened to Trulieve Cannabis’s price movement after its last earnings report?
                  Trulieve Cannabis reported an EPS of C$0.175 in its last earnings report, missing expectations of C$0.331. Following the earnings report the stock price went down -0.619%.
                    Which hedge fund is a major shareholder of Trulieve Cannabis?
                    Currently, no hedge funds are holding shares in TSE:TRUL

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis